FR3112686B3 - Composition comprenant un mélange d’extraits de Vitis vinifera et de Vaccinium angustifolium et des probiotiques pour améliorer les fonctions cognitives - Google Patents

Composition comprenant un mélange d’extraits de Vitis vinifera et de Vaccinium angustifolium et des probiotiques pour améliorer les fonctions cognitives Download PDF

Info

Publication number
FR3112686B3
FR3112686B3 FR2007796A FR2007796A FR3112686B3 FR 3112686 B3 FR3112686 B3 FR 3112686B3 FR 2007796 A FR2007796 A FR 2007796A FR 2007796 A FR2007796 A FR 2007796A FR 3112686 B3 FR3112686 B3 FR 3112686B3
Authority
FR
France
Prior art keywords
composition
mixture
probiotics
vitis vinifera
cognitive functions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2007796A
Other languages
English (en)
Other versions
FR3112686A3 (fr
Inventor
David Gaudout
Stéphane Rey
Benoît Lemaire
Séverine Dubreuil
Camille Pouchieu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Activinside SAS
Original Assignee
Activinside SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Activinside SAS filed Critical Activinside SAS
Priority to FR2007796A priority Critical patent/FR3112686B3/fr
Priority to PCT/EP2021/070733 priority patent/WO2022018281A2/fr
Priority to DKBA202100060U priority patent/DK202100060U3/da
Priority to AU2021107611A priority patent/AU2021107611A4/en
Priority to PL438609A priority patent/PL438609A1/pl
Publication of FR3112686A3 publication Critical patent/FR3112686A3/fr
Application granted granted Critical
Publication of FR3112686B3 publication Critical patent/FR3112686B3/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition nutritionnelle ou pharmaceutique comprenant au moins un mélange d’extraits de Vitis vinifera et de Vaccinium angustifolium, et au moins une bactérie probiotique et/ou levure probiotique. Une telle composition est destinée à être utilisé comme produit nutritionnel ou médicament pour améliorer les fonctions cognitives chez l’Homme ou l’animal
FR2007796A 2020-07-24 2020-07-24 Composition comprenant un mélange d’extraits de Vitis vinifera et de Vaccinium angustifolium et des probiotiques pour améliorer les fonctions cognitives Active FR3112686B3 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR2007796A FR3112686B3 (fr) 2020-07-24 2020-07-24 Composition comprenant un mélange d’extraits de Vitis vinifera et de Vaccinium angustifolium et des probiotiques pour améliorer les fonctions cognitives
PCT/EP2021/070733 WO2022018281A2 (fr) 2020-07-24 2021-07-23 Composition comprenant un melange d'extraits de vitis vinifera et de vaccinium angustifolium et des probiotiques pour ameliorer les fonctions cognitives
DKBA202100060U DK202100060U3 (da) 2020-07-24 2021-07-26 Sammensætning omfattende en blanding af Vitis vinifera- og Vaccinium angustifoliumekstrakter og probiotika til forbedring af kognitive funktioner
AU2021107611A AU2021107611A4 (en) 2020-07-24 2021-07-26 Composition comprising a mixture of vitis vinifera and vaccinium angustifloium extracts and probiotics for improving cognitive functions
PL438609A PL438609A1 (pl) 2020-07-24 2021-07-26 Kompozycja zawierająca mieszaninę ekstraktów z Vitis vinifera i Vaccinium angustifolium oraz probiotyki dla poprawy funkcji poznawczych

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2007796 2020-07-24
FR2007796A FR3112686B3 (fr) 2020-07-24 2020-07-24 Composition comprenant un mélange d’extraits de Vitis vinifera et de Vaccinium angustifolium et des probiotiques pour améliorer les fonctions cognitives

Publications (2)

Publication Number Publication Date
FR3112686A3 FR3112686A3 (fr) 2022-01-28
FR3112686B3 true FR3112686B3 (fr) 2022-07-29

Family

ID=78032387

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2007796A Active FR3112686B3 (fr) 2020-07-24 2020-07-24 Composition comprenant un mélange d’extraits de Vitis vinifera et de Vaccinium angustifolium et des probiotiques pour améliorer les fonctions cognitives

Country Status (5)

Country Link
AU (1) AU2021107611A4 (fr)
DK (1) DK202100060U3 (fr)
FR (1) FR3112686B3 (fr)
PL (1) PL438609A1 (fr)
WO (1) WO2022018281A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3132221A1 (fr) * 2022-01-28 2023-08-04 Activ'inside Utilisation d’un mélange de flavanols pour augmenter la concentration de la forme active de la vitamine D, le calcitriol.
CN115300532B (zh) * 2022-09-20 2023-10-20 中加健康工程研究院(合肥)有限公司 具改善阿尔兹海默病认知能力的益生菌剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2899768B1 (fr) * 2006-04-14 2008-06-20 Juva Sante Soc Par Actions Sim Complement alimentaire antioxydant contenant des oligoproanthocyanides, du gamma-tocopherol, des catechines et biflavanes, de l'acide carnosique et du carnosol
EP2710901A1 (fr) * 2012-09-20 2014-03-26 Symrise AG Composition de supplément diététique
FR3042712B1 (fr) * 2015-10-27 2019-05-03 Activ'inside Agent nutritionnel ou therapeutique particulier comprenant un melange de raisin et de bleuet
CN108601372A (zh) * 2015-10-27 2018-09-28 特种宠物食品公司 用于宠物的协同有效的抗氧化剂组合物
US11122832B2 (en) * 2016-03-07 2021-09-21 Nature's Sunshine Products, Inc. Methods and compositions to improve weight loss and cardiometabolic health beyond diet and excercise
CN107334025A (zh) * 2017-08-08 2017-11-10 安徽永骏生物科技有限公司 一种蓝莓发酵饮料
FR3088540B1 (fr) * 2018-11-21 2023-05-12 Activinside UTILISATION EN PRISE UNIQUE D’UNE COMPOSITION comprenant un melange PARTICULIER D’EXTRAIT DE RAISINS ET D’EXTRAIT DE BLEUETS

Also Published As

Publication number Publication date
AU2021107611A4 (en) 2022-01-06
WO2022018281A3 (fr) 2022-03-10
WO2022018281A2 (fr) 2022-01-27
DK202100060U3 (da) 2021-10-26
PL438609A1 (pl) 2022-01-31
FR3112686A3 (fr) 2022-01-28

Similar Documents

Publication Publication Date Title
Segura-Campos et al. Biological potential of chia (Salvia hispanica L.) protein hydrolysates and their incorporation into functional foods
FR3112686B3 (fr) Composition comprenant un mélange d’extraits de Vitis vinifera et de Vaccinium angustifolium et des probiotiques pour améliorer les fonctions cognitives
JP5010024B2 (ja) 動物飼料用添加剤
US8449878B2 (en) Prebiotic formulations for use with probiotics to increase probiotic growth rate and activity
TWI568360B (zh) The use of cashew nut shell oil
AU741087B2 (en) Oregano for the treatment of internal parasites and protozoa
FR3076997B1 (fr) Extrait obtenu a partir de plusieurs plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin
US6426099B1 (en) Herbal formulation for rebuilding intestinal bacteria
MA33756B1 (fr) Melange antifongique comportant l'organisme fongique pythium oligandrum
DE602004012289D1 (de) Bioaktive peptide, die durch enzymatische hydrolyse aus den proteinen von eiweiss gewonnen werden
JP7092785B2 (ja) 飼料添加物製剤ならびにその製造方法および使用方法
Laloučková et al. In vitro antimicrobial effect of palm oils rich in medium-chain fatty acids against mastitis-causing Gram-positive bacteria.
RU2229286C2 (ru) Мазь ибупрофена, приготовленная на полиэтиленоксидной основе, обладающая противовоспалительным действием
FR3120188B3 (fr) Composition comprenant un extrait deVitis vinifera, de la vitamine C et des probiotiques pour lutter contre le vieillissement de la peau
JP6558793B2 (ja) アトピー性皮膚炎の予防治療用組成物、並びに当該予防治療用組成物を配合してなる医薬組成物、化粧料組成物及び機能性食品
Bamigboye et al. Ameliorative effect of Lentinus squarrosulus mycomeat against Pseudomonas aeruginosa infection using albino rat as animal model
ES2657610T3 (es) Micropartículas de aceite esencial y usos de las mismas para prevenir enfermedades entéricas
Khaldi et al. Contribution to the research of antibiotic residues in food of animal origin in the western regions of Algeria.
Shakib et al. Evaluation of the Antibacterial Effect of Garlic and Ginger on ESBL and KPC-Producing Pseudomonas aeruginosa Strains
CO et al. Ameliorative effect of Lentinus squarrosulus mycomeat against Pseudomonas aeruginosa infection using albino rat as animal model
Mourand et al. Time evolution of resistance and virulence of broilers intestinal Escherichia coli.
Maghraby et al. Effect of antioxidative properties of honey on Schistosoma mansoni-infected mice.
Stachelek et al. ACCEPTED AUTHOR VERSION OF THE MANUSCRIPT: Overcoming bacterial resistance to antibiotics: the urgent needs
Sivakumar et al. CURRICULAM VITE
BG98915A (en) Medicamentous phytopreparation having balanced polyvitamin, phytoncidic and steroid-saponific composition

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4